Cytology and HPV Testing Market - Global Industry Analysis, Size, Share, Growth, Current Demand, and Development Report

TMR’s report on the global cytology and HPV testing market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cytology and HPV testing market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cytology and HPV testing market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cytology and HPV testing market.

Request Brochure for Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2216

Global Cytology and HPV Testing market Witness Most Promising Rise in Demand

HPV infection is one of the most common causes of cervical cancer. It accounts for about 90% of cervical cancer cases and is diagnosed through Pap smear screening and HPV testing.The spread of HPV infection poses a great threat to an individual’s immune system and leads to the conversion of normal cervix cells into cancerous cells. Two types of HPV infections — HPV 16 and HPV 18 — account for 70% of the overall cervical cancer cases and are termed as “high-risk” infections.

According to the World Health Organization (WHO), cervical cancer is the most prevalent HPV-related disease, with an estimated 530,000 new cases every year. Furthermore, according to the Cancer Research UK, about 3,100 women are diagnosed with cervical cancer each year in the country.Various factors contributing to the high incidence rate of HPV infections include weakened immune system, smoking, chronic inflammation and long-term oral contraceptive use. The International Agency for Research and Cancer predicted that the rate of HPV related cervical cancer would rise by 40% in the near future.Hence, HPV infection remains one of the leading causes of cervical cancer and rising prevalence and incidence rates are expected to drive the growth of the market

According to Transparency Market Research’s latest report on the global cytology and HPV testing market for the historical period 2017–2018 and forecast period 2019–2027, high incidence rate of HPV infections and increasing incidence of cervical cancer worldwide are projected to drive the global cytology and HPV testing market during the forecast period

According to the report, the global cytology and HPV testing market was valued at US$ 7.42 Bn in 2018 and is anticipated to expand at a CAGR of 5.9% from 2019 to 2027

Request for Analysis of COVID19 Impact on Cytology and HPV Testing Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2216

The report on the global cytology and HPV Testing market discussed individual strategies, followed by company profiles of manufacturers of cytology and HPV Testing. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cytology and HPV Testing market.

Top of Form

Key Players of Cytology and HPV Testing Market Report:

Top of Form

This report profiles major players in the global cytology and HPV testing market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Leading players operating in the global cytology and HPV testing market are

Becton
Dickinson and Company
Cepheid, Inc.
Abbott Laboratories, Inc.
Hoffmann-La Roche AG
Fujirebio Diagnostics, Inc.
Arbor Vita Corporation
Hologic, Inc.
QIAGEN N.V.
OncoHealth Corporation
Buy Cytology and HPV Testing Market Report –

https://www.transparencymarketresearch.com/checkout.php?rep_id=2216<ype=S

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.